TABLE 2.
Strains, derived isogenic isolates, and plasmids used in the present work
| Strain or plasmid | Relevant featuresa | Reference or source |
|---|---|---|
| Salmonella strains | ||
| 3246 | S. Dublin wild-type, bstA-positive strain | 22 |
| 4/74 | S. Typhimurium wild-type, virulent reference strain | 23 |
| KP1274 | Escherichia coli restriction-deficient strain | 38 |
| ΔbstA | S. Dublin 3246 lacking bstA, Aprr | This work |
| 3246-C | S. Dublin ΔbstA complemented with bstA by pACY177 + bstA::pAHF4, Aprr Knr | This work |
| 3246/pACY177 | S. Dublin 3246 containing pACY177 | This work |
| invH201::TnphoA | 4/74 lacking invH, Knr | 35 |
| 4/74 ΔssaV | 4/74 lacking ssaV, SPI2-T3SS defect, Knr | This work |
| Plasmids | ||
| pACY177 | Cloning vector, Apr Knr | 39 |
| pAHF4 | pACY177 expressing bstA, Knr | 10 |
| pKD46 | Plasmid with bacteriophage λ red recombinase expressed from an arabinose-inducible promoter, Apr | 32 |
| pUO9090 | Aprr | Unpublished |
| pKD4 | Knr | 32 |
Aprr, Knr, and Apr, apramycin, kanamycin, and ampicillin resistant, respectively.